Literature DB >> 19795467

Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors.

Fabiana Novellino1, Gennarina Arabia, Antonio Bagnato, Giuseppe Lucio Cascini, Maria Salsone, Giuseppe Nicoletti, Demetrio Messina, Maurizio Morelli, Sandra Paglionico, Laura Giofrè, Antonino Restuccia, Giusi Torchia, Francesca Condino, Aldo Quattrone.   

Abstract

The cooccurrence of rest and postural tremor (mixed tremor) as the predominant clinical manifestation in patients who do not fulfill diagnostic established criteria for essential tremor (ET) or Parkinson's disease (PD) poses a clinical diagnostic challenge. Twenty-two patients with mixed tremor and additional mild extrapyramidal features, such as bradykinesia and rigidity, 20 patients with probable PD, 10 patients with probable ET, and 18 controls were investigated through the combined use of dopamine transporter (123)I-FP-CIT-single-photon emission tomography (DAT-SPECT) and cardiac (123)metaiodobenzylguanidine (MIGB) scintigraphy. Six of the 22 mixed-tremor patients had normal DAT-SPECT, a condition usually found in patients with ET, whereas 16 patients showed damage to the nigrostriatal system. Cardiac MIBG allowed further differentiation between these 16 patients because eight of them had decreased tracer uptakes (heart/mediastinum [H/M] ratio in delayed image, H/M ratio delayed: 1.16 +/- 0.11, P < 0.001 vs controls), indicating a PD, whereas the remaining eight had normal cardiac tracer uptakes, a finding suggestive of a parkinsonian syndrome (H/M ratio delayed: 1.90 +/- 0.13). Both DAT-SPECT and cardiac MIBG scintigraphies were abnormal in the 20 patients with probable PD, whereas these were normal in both the patients with probable ET as well as in the controls. Our study suggests that the combined use of both DAT-SPECT and MIBG scintigraphy in mixed tremors with additional extrapyramidal features can help distinguish patients with ET from those with PD and parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795467     DOI: 10.1002/mds.22771

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

Review 1.  MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason; Antonella Stefanelli; Fabrizio Cocciolillo; Daniela Di Giuda; Giorgio Fagioli; Alessandro Giordano
Journal:  Clin Auton Res       Date:  2011-07-27       Impact factor: 4.435

2.  The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson's Disease from Other Parkinsonian Syndromes.

Authors:  Eiji Matsusue; Yoshio Fujihara; Kenichiro Tanaka; Yuki Aozasa; Manabu Shimoda; Hiroyuki Nakayasu; Kazuhiko Nakamura; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

3.  A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.

Authors:  Yu Iwabuchi; Masashi Kameyama; Yohji Matsusaka; Hidetoshi Narimatsu; Masahiro Hashimoto; Morinobu Seki; Daisuke Ito; Hajime Tabuchi; Yoshitake Yamada; Masahiro Jinzaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-03       Impact factor: 9.236

Review 4.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

5.  Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography.

Authors:  Hua-Guang Zheng; Rong Zhang; Xin Li; Fang-Fei Li; Ya-Chen Wang; Xue-Mei Wang; Ling-Long Lu; Tao Feng
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

Review 6.  Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm.

Authors:  J William Langston; Jesse C Wiley; Michele Tagliati
Journal:  NPJ Parkinsons Dis       Date:  2018-02-23

7.  123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.

Authors:  Susanna Nuvoli; Angela Spanu; Maria Rita Piras; Antonio Nieddu; Aldo Mulas; Gaia Rocchitta; Grazia Galleri; Pier Andrea Serra; Giuseppe Madeddu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.

Authors:  Naoto Uyama; Hideki Otsuka; Takayoshi Shinya; Yoichi Otomi; Masafumi Harada; Wataru Sako; Yuishin Izumi; Ryuji Kaji; Yuya Watanabe; Satoru Takashi; Yamato Kunikane
Journal:  Nucl Med Commun       Date:  2017-06       Impact factor: 1.690

9.  Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.

Authors:  Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Nayuta Namioka; Hirokuni Hatanaka; Daisuke Hirose; Raita Fukasawa; Takahiko Umahara; Hirohumi Sakurai; Haruo Hanyu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-02       Impact factor: 9.236

10.  Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinsons Disease from Essential Tremor and Healthy Individuals.

Authors:  Gabriel Henrique Almeida Antonio Bienes; Caroline de Pietro Franco Zorzenon; Ernesto Duarte Alves; Lus Antnio Tobaru Tibana; Vanderci Borges; Henrique Carrete; Henrique Ballalai Ferraz
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.